CatSci Announces Partnership with Shimadzu
22nd March 2021
CatSci Ltd, a scientifically-led, commercially-minded and award-winning innovation partner for medicines development, is delighted to announce its collaboration with Shimadzu Corporation to equip its new analytical laboratory in Dagenham, UK. This collaboration will provide CatSci’s customers with access to state-of-the-art analytical equipment and solidify the UK as a centre for excellence in the global pharmaceutical development industry.
CatSci is enhancing its capabilities in analytical science delivering excellence in measurement science to better serve its customers ever-evolving needs and de-risk their pharmaceutical pipeline. CatSci’s enhanced capabilities will include addressing new modalities and asset classes, such as oligonucleotides, alongside additional capacity for GMP analytical testing. This expansion will be supported by a £3 million investment over the next two years and the opening of its second site in Dagenham, in April 2021.
Shimadzu is one of the world leaders in analytical instrumentation and solutions. Its superior, world-class technologies enable its customers to develop new products that promote people’s health and support the protection of the environment.
Partnering with Shimadzu reflects CatSci’s evolution to always provide ‘more and better’ for its customers so that they can deliver best-in-class therapeutics to those in need. It also means that CatSci can match and even surpass its customers internal capabilities enabling them making critical decisions right first time every time.
Dr Nigel Richardson, Director of Analytical Technology and New Modalities at CatSci, said: “We are delighted to be partnering with Shimadzu to build the new CatSci analytical laboratory at LondonEast, Dagenham, UK. Through this collaboration we will power the delivery of tailored analytical solutions to our customers with access to state-of-art equipment and engineering. Together with Shimadzu, we aim to set a new exemplary standard for measurement science to expedite medicines development.”
Dr Lee Parry, Sales & Marketing Manager at Shimadzu UK, said: “Uniting CatSci’s vast scientific knowledge and analytical experience with Shimadzu’s cutting-edge equipment and best-in-class support enables us to work together and solve important challenges faced by the industry. Shimadzu UK are thrilled to be joining forces with such an ambitious and forward-thinking company that has such a strong reputation for delivering excellent solutions for customers. The new CatSci laboratory in Dagenham, UK, is a great step towards a very exciting future.”
You can read Shimadzu’s news item about our collaboration here: https://www.shimadzu.co.uk/catsci-collaboration